Zhaoke Ophthalmology Limited

HKSE 6622.HK

Zhaoke Ophthalmology Limited Total Assets for the year ending December 31, 2023

Zhaoke Ophthalmology Limited Total Assets is NA for the year ending December 31, 2023. Total assets are the total value of all assets owned by a company, representing its resources.

Zhaoke Ophthalmology Limited Total Assets for the year ending December 31, 2022 was USD 372.51 M, a -9.15% change year over year.
Zhaoke Ophthalmology Limited Total Assets for the year ending December 31, 2021 was USD 410.04 M, a 118.21% change year over year.
Zhaoke Ophthalmology Limited Total Assets for the year ending December 31, 2020 was USD 187.91 M, a 136.12% change year over year.
Zhaoke Ophthalmology Limited Total Assets for the year ending December 31, 2019 was USD 79.59 M.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

HKSE: 6622.HK

Zhaoke Ophthalmology Limited

CEO	Dr. Xiaoyi Li Ph.D.
IPO Date	April 29, 2021
Location	China
Headquarters	No. 1 Meide 3rd Road
Employees	297
Sector	Health Care
Industries Pharmaceuticals Eyewear

Description

Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.

Key trends

Past 5 years